to a Leeds and Northrup Cleretrend 12 point recorder, provision being made for matching the photocell outputs. The recorder selects each channel in turn and prints a dot corresponding to the deflection from that channel. At the paper speed of 3 in. per hour the resultant trace is a continuous line. Channel identification is by colour and number. This type of recorder was chosen after careful consideration of those available and has proved satisfactory.
Future systems would be improved by the addition of a multipoint selector, now available for this particular recorder, which allows those channels not in use to be kept clear of the chart. In the present machine, a built-in test circuit, when switched on, applies different millivolt potentials to each channel not in use, allowing those channels to trace out steady lines and thus avoid confusion with channels carrying clot lysis information. A photograph of the complete assembly is shown in Figure 3 . Figure 4 shows the good reproducibility from an actual record of two sets of six identical clots. (The clots were transferred from a water bath at 37°C. to the lysis chamber 80 min. after the addition of thrombin).
RESULTS
Preliminary investigations have shown that the basic instrument can be modified to record the lysis times of the clot system described by Hawkey and Stafford (1964 ), Nanninga, Zeller, and Maynes (1964 ), and Mann (1966 . Provision has also been made in the circuit to allow a faster paper speed recorder to be connected to any channel to observe clotting times.
CONCLUSION
The instrument described permits the automatic simultaneous recording of the lysis time of up to 12 euglobulin clots. It can also be used for other clot lysis systems. Its usefulness is based upon its objectivity, simplicity of operation, and the economic use of the laboratory worker's time. This instrument is now commercially available from Carmanan Instrumentation Ltd, 2, Nanninga, L. B., Zeller, R., and Maynes, C. (1964 Methaemalbumin has a characteristic absorption spectrum which changes on the addition of reducing agents such as dithionite (Fig. 1 ). This change, which is due to the formation of haemalbumin (Fairley, 1941) , can be used as a basis for the measurement of methaemalbumin. To 2 ml. of plasma (or serum) is added 1-0 ml. of phosphate buffer (1 M, pH 7 4). The mixture is centrifuged for 5 min. to remove traces of fibrin and any remaining cells and the absorbance measured at 569 m,u in a spectrophotometer such as the Unicam SP500. The solution is then returned to a test-tube and a small amount (about 5 mg.) of solid sodium dithionite added. The tube is shaken gently to dissolve the dithionite and left for 5 min. to allow complete reduction of methaemalbumin. The absorbance at 569 m,u is again determined and the increase computed.
The concentration of methaemalbumin is obtained from a calibration graph. This is constructed from readings obtained with methaemalbumin solutions of known concentration (1 to 10 mg./100 ml., as haemin) prepared by dissolving haemin (British Drug Houses) in a minimum volume of 1 M NaOH and adding this immediately to a solution (4% w/v) of human serum albumin.
Measurement of absorbance before and after addition of dithionite avoids interference due to background colour or to turbidity which invalidate the spectro- scopic method proposed by Shinowara and Walters (1963) . Oxyhaemoglobin, which sometimes accompanies methaemalbumin in plasma, e.g., after recent haemolysis, is converted by dithionite to haemoglobin, with change in absorption spectrum but oxyhaemoglobin does not interfere in this method because, at the chosen wavelength, oxyhaemoglobin and haemoglobin have identical absorption coefficients. However, the change in absorbance of both oxyhaemoglobin and haemoglobin with change in wavelength at this point is considerable and a check should be made, using a solution of oxyhaemoglobin, that the wavelength setting on the spectrophotometer is correct in this respect.
The validity of the method proposed here depends on the absence of any other substance in plasma which is affected by dithionite with significant change in absorbance at 569 m,u. We have examined in this respect a number of normal and pathological plasmas, including some from jaundiced patients, and have found no evidence for such interference. 
